<SEC-DOCUMENT>0001415889-23-009134-index.html : 20230602
<SEC-HEADER>0001415889-23-009134.hdr.sgml : 20230602
<ACCEPTANCE-DATETIME>20230602200028
ACCESSION NUMBER:		0001415889-23-009134
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20230531
FILED AS OF DATE:		20230602
DATE AS OF CHANGE:		20230602

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Bazemore Todd
		CENTRAL INDEX KEY:			0001605767

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38150
		FILM NUMBER:		23990916

	MAIL ADDRESS:	
		STREET 1:		C/O DYAX CORP.
		STREET 2:		55 NETWORK DRIVE
		CITY:			BURLINGTON
		STATE:			MA
		ZIP:			01803

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Kala Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001479419
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				270604595
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		1167 MASSACHUSETTS AVENUE
		CITY:			ARLINGTON
		STATE:			MA
		ZIP:			02476
		BUSINESS PHONE:		781-996-5252

	MAIL ADDRESS:	
		STREET 1:		1167 MASSACHUSETTS AVENUE
		CITY:			ARLINGTON
		STATE:			MA
		ZIP:			02476
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4-06022023_080605.xml
<TEXT>
Document 1 - file: form4-06022023_080605.html

Document 1 - RAW XML: form4-06022023_080605.xml

</DOCUMENT>
</SEC-DOCUMENT>